NCT03814278

Brief Summary

Antepartum bed rest is widely prescribed after preterm premature rupture of the membranes (PPROM), although its effectiveness to prevent preterm birth has not been demonstrated. This pilot randomized controled trial (RCT) aims to access the impact of bed rest in maternal and neonatal outcomes in pregnancies complicated by premature rupture of the membranes.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2012

Longer than P75 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2012

Completed
5.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2017

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2018

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

November 23, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

January 24, 2019

Completed
Last Updated

January 30, 2019

Status Verified

January 1, 2019

Enrollment Period

5.9 years

First QC Date

November 23, 2018

Last Update Submit

January 28, 2019

Conditions

Outcome Measures

Primary Outcomes (2)

  • Latency time

    Time between preterm premature rupture of the membranes and delivery, in days

    From preterm premature rupture of the membranes until delivery, estimated average time of one week

  • Chorioamnionitis

    Incidence of clinical chorioamnionitis (defined as maternal fever plus leukocytosis and CRP elevation, or as maternal fever plus any two of the following: fetal tachycardia; maternal tachycardia; uterine tenderness; purulent amniotic fluid)

    From preterm premature rupture of the membranes until delivery, estimated average time of one week

Study Arms (2)

Complete bed rest

EXPERIMENTAL

Participants on complete bed rest group kept antepartum confinement to bed with toileting restricted to bedpan use. Participants in this group received prophylactic subcutaneous enoxaparin (40mg/day).

Behavioral: complete bed rest

Activity restriction group

EXPERIMENTAL

Activity restriction group had motion limited to bathroom privileges and walks to the ward canteen four times per day.

Behavioral: activity restriction

Interventions

Patients in this group received standard care for PPROM according to the institution protocol, including antepartum confinement to bed.

Complete bed rest

Patients in this group received standard care for PPROM according to the institution protocol but to had bathroom privileges and walks to the ward canteen four times per day.

Activity restriction group

Eligibility Criteria

Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsPatient eligibility is based on gender identity because we will include only pregnant women
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • single pregnancies AND
  • PPROM at 24+0-33+6 weeks of gestation AND
  • admitted to our tertiary center.

You may not qualify if:

  • indication for immediate delivery on admission (chorioamnionitis, placenta abruption, cord prolapse, signs of fetal hypoxia/distress)
  • fetal malformations
  • multiple gestation
  • maternal immunosuppressive disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Preterm Premature Rupture of the Membranes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor, Principal Investigator

Study Record Dates

First Submitted

November 23, 2018

First Posted

January 24, 2019

Study Start

January 1, 2012

Primary Completion

December 1, 2017

Study Completion

January 1, 2018

Last Updated

January 30, 2019

Record last verified: 2019-01